Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 4
Submit an article Journal homepage
861
Views
11
CrossRef citations to date
0
Altmetric
Editorial

Meta-analysis and metagenes

CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome

Davide Bedognetti Infectious Disease and Immunogenetics Section; Department of Transfusion Medicine; Clinical Center and Trans-NIH Center for Human Immunology; National Institutes of Health; Bethesda, MD USACorrespondence[email protected]
,
Ena Wang Infectious Disease and Immunogenetics Section; Department of Transfusion Medicine; Clinical Center and Trans-NIH Center for Human Immunology; National Institutes of Health; Bethesda, MD USA; Research Branch; Sidra Medical and Research Centre; Doha, Qatar
&
Francesco M Marincola Infectious Disease and Immunogenetics Section; Department of Transfusion Medicine; Clinical Center and Trans-NIH Center for Human Immunology; National Institutes of Health; Bethesda, MD USA; Research Branch; Sidra Medical and Research Centre; Doha, Qatar
Article: e28727 | Received 01 Mar 2014, Accepted 01 Mar 2014, Published online: 09 Apr 2014

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jie Zhang & Dawei Hu. (2021) miR-1298-5p Influences the Malignancy Phenotypes of Breast Cancer Cells by Inhibiting CXCL11. Cancer Management and Research 13, pages 133-145.
Read now
Wouter Hendrickx, Ines Simeone, Samreen Anjum, Younes Mokrab, François Bertucci, Pascal Finetti, Giuseppe Curigliano, Barbara Seliger, Luigi Cerulo, Sara Tomei, Lucia Gemma Delogu, Cristina Maccalli, Ena Wang, Lance D. Miller, Francesco M. Marincola, Michele Ceccarelli & Davide Bedognetti. (2017) Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis. OncoImmunology 6:2.
Read now

Articles from other publishers (9)

Sashana Dixon, Alice Tran, Matthew Schrier & Malav Trivedi. 2022. Engineering Technologies and Clinical Translation. Engineering Technologies and Clinical Translation 331 356 .
Mariya Rozenblit, Wouter Hendrickx, Adriana Heguy, Luis Chiriboga, Cynthia Loomis, Karina Ray, Farbod Darvishian, Mikala Egeblad, Sandra Demaria, Francesco M. Marincola, Davide Bedognetti & Sylvia Adams. (2019) Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod. Scientific Reports 9:1.
Crossref
Sangeetha Prabhakaran, Victoria T. Rizk, Zhenjun Ma, Chia-Ho Cheng, Anders E. Berglund, Dominico Coppola, Farah Khalil, James J. Mulé & Hatem H. Soliman. (2017) Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes. Breast Cancer Research 19:1.
Crossref
Chunyan Gu-Trantien, Edoardo Migliori, Laurence Buisseret, Alexandre de Wind, Sylvain Brohée, Soizic Garaud, Grégory Noël, Luan Dang C.V.Jean-Nicolas Lodewyckx, Céline Naveaux, Hugues Duvillier, Stanislas Goriely, Denis Larsimont & Karen Willard-Gallo. (2017) CXCL13-producing TFH cells link immune suppression and adaptive memory in human breast cancer. JCI Insight 2:11.
Crossref
Shu Wang, Jose Campos, Marilena Gallotta, Mei Gong, Chad Crain, Edwina Naik, Robert L. Coffman & Cristiana Guiducci. (2016) Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8 + T cells . Proceedings of the National Academy of Sciences 113:46.
Crossref
Davide Bedognetti, Cristina Maccalli, Salha B.J. Al Bader, Francesco M. Marincola & Barbara Seliger. (2016) Checkpoint Inhibitors and Their Application in Breast Cancer. Breast Care 11:2, pages 108-115.
Crossref
Zhaojun Duan, Jian Gao, Ling Zhang, Hua Liang, Xiangbo Huang, Qiang Xu, Yu Zhang, Tao Shen & Fengmin Lu. (2015) Phenotype and function of CXCR5+CD45RA−CD4+ T cells were altered in HBV-related hepatocellular carcinoma and elevated serum CXCL13 predicted better prognosis. Oncotarget 6:42, pages 44239-44253.
Crossref
Davide Bedognetti, Wouter Hendrickx, Francesco M. Marincola & Lance D. Miller. (2015) Prognostic and predictive immune gene signatures in breast cancer. Current Opinion in Oncology 27:6, pages 433-444.
Crossref
Davide Bedognetti, Sara Tomei, Wouter Hendrickx, Francesco M. Marincola & Ena Wang. 2015. Developments in T Cell Based Cancer Immunotherapies. Developments in T Cell Based Cancer Immunotherapies 99 127 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.